Abstract
This trial studies how well fimepinostat works in treating patients with newly diagnosed
diffuse intrinsic pontine glioma, or medulloblastoma, or high-grade glioma that have come
back. Fimepinostat may stop the growth of tumor cells by blocking some of the enzymes needed
for cell growth.
